CTSS and interstitial lung disease: Clinically, serum CTSS levels serve as biomarkers for interstitial lung disease and uveitis, while preclinical studies validate its therapeutic targeting in multi-organ pathologies affecting pulmonary, hepatic, cardiovascular, and neural systems.